Tagged with GI

Switzerland From regenerating damaged muscles to rewriting the cell manufacturing playbook, Switzerland’s next wave of biotech innovators is turning regenerative medicine into a precision science. Once considered futuristic, technologies like autologous tissue grafts, gene-edited therapies, and cell-state reprogramming are now gaining real-world traction with Swiss startups at the forefront. These five…

Puerto Rico From its origins as a modest logistics firm in 1982, GMD Airline Services has grown into a critical enabler of Puerto Rico’s pharmaceutical and medical device supply chain. At the intersection of ground handling, cold chain operations, and air cargo connectivity, GMD’s evolution reflects the broader shifts in the island’s…

Switzerland Antoine Geissbühler wears many hats—physician, academic, innovator, and institutional leader—and is at the forefront of digital transformation in healthcare. In this wide-ranging conversation, the Dean of the Faculty of Medicine at the University of Geneva and President of the BioAlps Association shares his journey, insights into Geneva’s unique life sciences…

Denmark Already one of Europe’s top countries for clinical trials per capita, Denmark has further strengthened its position in recent years. The number of active trials in the country rose from 410 in 2022 to 450 in 2023, backed by increasing citizen participation and a healthcare ecosystem built on trusted health…

Switzerland The transformation of CEVA Logistics’ healthcare strategy – led by industry veteran Eric ten Kate – is unfolding with quiet precision and sharp focus. As part of the CMA CGM Group and with a mandate rooted in operational excellence, digital intelligence, and regional depth, CEVA is redefining its position in…

Switzerland Nasri Nahas, CEO of Biopôle, shares his vision for one of Europe’s leading life sciences innovation parks and its evolving role within the national and international healthcare ecosystem. In this interview, Nasri discusses Biopôle’s key priorities, including the integration of AI and data, sustainability in life sciences, and the importance…

Switzerland Once a traditional Swiss pharmaceutical wholesaler, Unipharma has undergone a profound transformation into a globally oriented, strategy-driven partner for hospitals, pharmaceutical, and biotechnology companies. Under the leadership of CEO Simone Maisto, the company has redefined its business model, streamlined its portfolio around high-value therapies, and expanded into emerging markets, all…

Switzerland SkyCell is at the forefront of a fundamental shift in pharmaceutical logistics, where AI, real-time monitoring, and sustainability are no longer optional but essential. As pharmaceutical supply chains grow more complex, the need for precision, resilience, and carbon-conscious innovation has never been greater. With AI-driven optimization redefining efficiency and risk…

Saudi Arabia Saudi Arabia is rapidly emerging as a leader in digital healthcare, where AI, cloud computing, and data-driven solutions are reshaping the industry. Mohammed Saleh, Health Director Part of Microsoft EMEA, shares how Microsoft is driving this transformation – enhancing patient care, streamlining operations, and enabling AI-powered clinical advancements. With a…

Saudi Arabia Lars Nielsen of Hellmann Worldwide Logistics Saudi Arabia shares his insights on the rapid growth and transformation of the logistics sector in the Kingdom. With over 30 years of experience in the industry, Nielsen discusses Hellmann’s strategic priorities—particularly in the healthcare vertical—and highlights the evolving role of digital technology and…

Puerto Rico Ivan Lugo, co-founder and board member of Puerto Rico’s Life Science Air Cargo Community, offers valuable insights into recent developments within the island’s logistics sector, particularly the formation of the industry organization. He discusses key advancements within the community, including the creation of a comprehensive cargo data platform and the…

LatAm A roundup of some of the biggest stories coming out of Latin American pharma and healthcare, including Mexico’s move to speed up the drug review process; Sanfer’s acquisition of Columbia’s Laboratorio Vitalis; Pfizer’s joint vaccine effort with PAHO and Argentinian drugmaker Sinergium Biotech, and the epilspsy joint venture between SK Biopharmaceuticals…